• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2X1和P2X7受体过表达是肌层浸润性膀胱癌生存的负性预测指标。

P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.

作者信息

Ledderose Stephan, Rodler Severin, Eismann Lennert, Ledderose Georg, Rudelius Martina, Junger Wolfgang G, Ledderose Carola

机构信息

Institute of Pathology, Ludwig Maximilian University, 80337 Munich, Germany.

Department of Urology, Ludwig Maximilian University, 81377 Munich, Germany.

出版信息

Cancers (Basel). 2023 Apr 16;15(8):2321. doi: 10.3390/cancers15082321.

DOI:10.3390/cancers15082321
PMID:37190249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10136747/
Abstract

Bladder cancer is amongst the most common causes of cancer death worldwide. Muscle-invasive bladder cancer (MIBC) bears a particularly poor prognosis. Overexpression of purinergic P2X receptors (P2XRs) has been associated with worse outcome in several malignant tumors. Here, we investigated the role of P2XRs in bladder cancer cell proliferation in vitro and the prognostic value of P2XR expression in MIBC patients. Cell culture experiments with T24, RT4, and non-transformed TRT-HU-1 cells revealed a link between high ATP concentrations in the cell culture supernatants of bladder cell lines and a higher grade of malignancy. Furthermore, proliferation of highly malignant T24 bladder cancer cells depended on autocrine signaling through P2X receptors. P2X1R, P2X4R, and P2X7R expression was immunohistochemically analyzed in tumor specimens from 173 patients with MIBC. High P2X1R expression was associated with pathological parameters of disease progression and reduced survival time. High combined expression of P2X1R and P2X7R increased the risk of distant metastasis and was an independent negative predictor of overall and tumor-specific survival in multivariate analyses. Our results suggest that P2X1R/P2X7R expression scores are powerful negative prognostic markers in MIBC patients and that P2XR-mediated pathways are potential targets for novel therapeutic strategies in bladder cancer.

摘要

膀胱癌是全球癌症死亡的最常见原因之一。肌层浸润性膀胱癌(MIBC)的预后特别差。嘌呤能P2X受体(P2XRs)的过表达与几种恶性肿瘤的较差预后相关。在此,我们研究了P2XRs在体外膀胱癌细胞增殖中的作用以及P2XR表达在MIBC患者中的预后价值。用T24、RT4和未转化的TRT-HU-1细胞进行的细胞培养实验揭示了膀胱细胞系细胞培养上清液中高ATP浓度与更高恶性程度之间的联系。此外,高恶性T24膀胱癌细胞的增殖依赖于通过P2X受体的自分泌信号传导。对173例MIBC患者的肿瘤标本进行了P2X1R、P2X4R和P2X7R表达的免疫组化分析。高P2X1R表达与疾病进展的病理参数和生存时间缩短相关。P2X1R和P2X7R的高联合表达增加了远处转移的风险,并且在多变量分析中是总生存和肿瘤特异性生存的独立负性预测指标。我们的结果表明,P2X1R/P2X7R表达评分是MIBC患者强有力的负性预后标志物,并且P2XR介导的途径是膀胱癌新治疗策略的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/58edcb156661/cancers-15-02321-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/42b1b6a72ad9/cancers-15-02321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/3d4ca28580ed/cancers-15-02321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/95c72bee1100/cancers-15-02321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/5dc37bd9686d/cancers-15-02321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/58edcb156661/cancers-15-02321-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/42b1b6a72ad9/cancers-15-02321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/3d4ca28580ed/cancers-15-02321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/95c72bee1100/cancers-15-02321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/5dc37bd9686d/cancers-15-02321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420a/10136747/58edcb156661/cancers-15-02321-g005.jpg

相似文献

1
P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.P2X1和P2X7受体过表达是肌层浸润性膀胱癌生存的负性预测指标。
Cancers (Basel). 2023 Apr 16;15(8):2321. doi: 10.3390/cancers15082321.
2
Physiopathological implications of P2X and P2X receptors in regulation of glomerular hemodynamics in angiotensin II-induced hypertension.P2X和P2X受体在血管紧张素II诱导的高血压中对肾小球血流动力学调节的病理生理意义
Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F9-F19. doi: 10.1152/ajprenal.00663.2016. Epub 2017 Apr 12.
3
Purinergic P2X receptor, purinergic P2X receptor, and angiotensin II type 1 receptor interactions in the regulation of renal afferent arterioles in angiotensin II-dependent hypertension.嘌呤能 P2X 受体、嘌呤能 P2X 受体和血管紧张素 II 型 1 受体在血管紧张素 II 依赖性高血压中调节肾入球小动脉中的相互作用。
Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1400-F1408. doi: 10.1152/ajprenal.00602.2019. Epub 2020 Apr 20.
4
Purinergic 2X 4 (P2X4), but not P2X7, receptors increase cytosolic [Ca] and stimulate mucin secretion in rat conjunctival goblet cells to maintain ocular surface health.嘌呤能2X4(P2X4)受体而非P2X7受体可增加大鼠结膜杯状细胞的胞质[Ca]并刺激黏蛋白分泌,以维持眼表健康。
Exp Eye Res. 2023 Oct;235:109614. doi: 10.1016/j.exer.2023.109614. Epub 2023 Aug 12.
5
Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.长链非编码RNA TUG1的过表达预示着高级别肌层浸润性膀胱癌的预后不良,并促进癌细胞增殖和迁移。
Tumour Biol. 2016 Oct;37(10):13385-13390. doi: 10.1007/s13277-016-5177-9. Epub 2016 Jul 27.
6
High P2X6 receptor expression in human bladder cancer predicts good survival prognosis.人膀胱癌中高表达 P2X6 受体预示良好的生存预后。
Mol Cell Biochem. 2022 Aug;477(8):2047-2057. doi: 10.1007/s11010-022-04425-0. Epub 2022 Apr 16.
7
Functional expression of P2X family receptors in macrophages is affected by microenvironment in mouse T cell acute lymphoblastic leukemia.P2X 家族受体在巨噬细胞中的功能表达受小鼠 T 细胞急性淋巴细胞白血病微环境的影响。
Biochem Biophys Res Commun. 2014 Apr 18;446(4):1002-9. doi: 10.1016/j.bbrc.2014.03.048. Epub 2014 Mar 21.
8
Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.嘌呤能抑制剂氧化型 ATP 在胰岛移植排斥模型中的作用。
Diabetes. 2013 May;62(5):1665-75. doi: 10.2337/db12-0242. Epub 2013 Jan 11.
9
ATP-evoked sustained vasoconstrictions mediated by heteromeric P2X1/4 receptors in cerebral arteries.三磷酸腺苷诱导的异源 P2X1/4 受体介导的脑动脉持续收缩。
Stroke. 2014 Aug;45(8):2444-50. doi: 10.1161/STROKEAHA.114.005544. Epub 2014 Jun 24.
10
Systematic analysis of gene expression profiles reveals prognostic stratification and underlying mechanisms for muscle-invasive bladder cancer.基因表达谱的系统分析揭示了肌肉浸润性膀胱癌的预后分层及潜在机制。
Cancer Cell Int. 2019 Dec 16;19:337. doi: 10.1186/s12935-019-1056-y. eCollection 2019.

引用本文的文献

1
Ap4A in Cancer: A Multifaceted Regulator and Emerging Therapeutic Target.癌症中的Ap4A:一个多面调节因子及新兴治疗靶点
Molecules. 2025 Jul 22;30(15):3056. doi: 10.3390/molecules30153056.
2
Role of P2X7 receptor in the progression and clinicopathological characteristics of gastric cancer.P2X7受体在胃癌进展及临床病理特征中的作用
Sci Rep. 2024 Dec 30;14(1):31673. doi: 10.1038/s41598-024-81515-7.
3
P2 purinergic receptor expression and function in tumor-related immune cells.P2嘌呤能受体在肿瘤相关免疫细胞中的表达与功能

本文引用的文献

1
Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation.结肠肿瘤细胞死亡通过旁分泌 P2X4 刺激引起 mTOR 依赖性。
Nature. 2022 Dec;612(7939):347-353. doi: 10.1038/s41586-022-05426-1. Epub 2022 Nov 16.
2
Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value-Need for Biomarker Testing in High-Risk Patients?Nectin-4在膀胱癌不同组织学类型中的表达及其预后价值——高危患者是否需要进行生物标志物检测?
Cancers (Basel). 2022 Sep 11;14(18):4411. doi: 10.3390/cancers14184411.
3
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors.
Purinergic Signal. 2024 Oct 10. doi: 10.1007/s11302-024-10054-7.
4
Structural insights into the human P2X1 receptor and ligand interactions.解析人类 P2X1 受体和配体相互作用的结构见解。
Nat Commun. 2024 Sep 28;15(1):8418. doi: 10.1038/s41467-024-52776-7.
5
The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma.嘌呤能通路在肾透明细胞癌预后评估和临床应用中的潜在价值。
Aging (Albany NY). 2024 Jan 4;16(1):246-266. doi: 10.18632/aging.205364.
6
Tumour immune escape via P2X7 receptor signalling.肿瘤通过 P2X7 受体信号逃逸免疫。
Front Immunol. 2023 Oct 30;14:1287310. doi: 10.3389/fimmu.2023.1287310. eCollection 2023.
7
The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk.P2X7受体在肿瘤发生和转移扩散中的作用:关于囊泡释放和腺苷能信号串扰的新见解
Int J Mol Sci. 2023 Sep 9;24(18):13906. doi: 10.3390/ijms241813906.
《2022 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类-第 B 部分:前列腺和泌尿系统肿瘤》。
Eur Urol. 2022 Nov;82(5):469-482. doi: 10.1016/j.eururo.2022.07.002. Epub 2022 Aug 11.
4
High P2X6 receptor expression in human bladder cancer predicts good survival prognosis.人膀胱癌中高表达 P2X6 受体预示良好的生存预后。
Mol Cell Biochem. 2022 Aug;477(8):2047-2057. doi: 10.1007/s11010-022-04425-0. Epub 2022 Apr 16.
5
P2x4 receptor promotes mammary cancer progression by sustaining autophagy and associated mesenchymal transition.P2x4 受体通过维持自噬和相关的间质转化促进乳腺癌的进展。
Oncogene. 2022 May;41(21):2920-2931. doi: 10.1038/s41388-022-02297-8. Epub 2022 Apr 11.
6
Optimized HPLC method to elucidate the complex purinergic signaling dynamics that regulate ATP, ADP, AMP, and adenosine levels in human blood.优化 HPLC 方法以阐明调节人血液中 ATP、ADP、AMP 和腺苷水平的复杂嘌呤能信号转导动力学。
Purinergic Signal. 2022 Jun;18(2):223-239. doi: 10.1007/s11302-022-09842-w. Epub 2022 Feb 7.
7
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.P2X4 嘌呤能受体为侵袭性前列腺癌提供了一个治疗靶点。
J Pathol. 2022 Feb;256(2):149-163. doi: 10.1002/path.5815. Epub 2021 Nov 25.
8
High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer.高CD39表达与人类膀胱癌的非肌肉浸润性表型相关。
Oncotarget. 2021 Aug 3;12(16):1580-1586. doi: 10.18632/oncotarget.28029.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
P2X receptors in cancer growth and progression.P2X受体在癌症生长和进展中的作用
Biochem Pharmacol. 2021 May;187:114350. doi: 10.1016/j.bcp.2020.114350. Epub 2020 Nov 28.